BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14677115)

  • 1. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
    Spiryda LB; Laufer MR; Soiffer RJ; Antin JA
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):760-5. PubMed ID: 14677115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
    Epstein JB; Reece DE
    Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management.
    Zantomio D; Grigg AP; MacGregor L; Panek-Hudson Y; Szer J; Ayton R
    Bone Marrow Transplant; 2006 Oct; 38(8):567-72. PubMed ID: 16953208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of topical cyclosporin A in ocular graft-versus-host-disease.
    Kiang E; Tesavibul N; Yee R; Kellaway J; Przepiorka D
    Bone Marrow Transplant; 1998 Jul; 22(2):147-51. PubMed ID: 9707022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A; Rózycki R
    Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnosis, surgical technique and follow-up.
    Costantini S; Di Capua E; Bosi S; Chiodi S; Spinelli S
    Minerva Ginecol; 2006 Feb; 58(1):11-6. PubMed ID: 16498366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tretinoin for the treatment of cutaneous graft-versus-host disease.
    Gryn J; Crilley P
    Bone Marrow Transplant; 1990 Apr; 5(4):279-80. PubMed ID: 2104506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN; Rao RD
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
    Malta JB; Soong HK; Shtein RM; Musch DC; Rhoades W; Sugar A; Mian SI
    Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
    Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA; Yalçindag N; Atilla H; Arat M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical acute graft-versus-host disease.
    Shin J; Hong W; Song H; Choi G; Kim YC
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.
    Stratton P; Turner ML; Childs R; Barrett J; Bishop M; Wayne AS; Pavletic S
    Obstet Gynecol; 2007 Nov; 110(5):1041-9. PubMed ID: 17978118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
    Epstein JB; Nantel S; Sheoltch SM
    Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of budesonide mouthwash on oral chronic graft versus host disease.
    Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
    Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of topical estrogens to labial fusion and vaginal introital integrity.
    Schober J; Dulabon L; Martin-Alguacil N; Kow LM; Pfaff D
    J Pediatr Adolesc Gynecol; 2006 Oct; 19(5):337-9. PubMed ID: 17060017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulvovaginal sequelae in toxic epidermal necrolysis.
    Meneux E; Paniel BJ; Pouget F; Revuz J; Roujeau JC; Wolkenstein P
    J Reprod Med; 1997 Mar; 42(3):153-6. PubMed ID: 9109082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal involvement in genital erosive lichen planus.
    Helgesen AL; Gjersvik P; Jebsen P; Kirschner R; Tanbo T
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):966-70. PubMed ID: 20583940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.